Durability II Study - www.legpainstudy.com DEFINITIVE™ Ca++ Study – www.legpaintrial.com Study to evaluate the use of the SilverHawk™ Plaque Excision System and the SpiderFX Embolic Protection Device in the endovascular treatment of moderate to severely calcified femoropopliteal artery lesions. DEFINITIVE™ LE Study A study designed confirm the value of plaque excision with the SilverHawk™ System. |
| Study of the investigational drug trans sodium crocetinate (TSC) in patients with Peripheral Arterial Disease (PAD) and leg pain with walking (intermittent claudication). |
Study on the use of using stem cells for Critical Limb Ischemia. |
![]()
Claudication: Exercise Versus Endoluminal Revascularization (CLEVER): The National Heart, Lung, and Blood Institute (NHLBI) is sponsoring a trial for patients with cardiovascular diseases, peripheral vascular diseases, or atherosclerosis to compare the effectiveness of aortic stent surgery versus exercise therapy.
To learn about more clinical trials, please visit the Vascular Disease Foundation's Clinical Trials Resource Center: www.vdf.org/clinical
This information is included for patient information only. The Vascular Disease Foundation does not endorse any clinical research studies.